Genmab A Income Statement (2018-2026) | GMAB

Income Statement Dec2018 Sep2019 Dec2019 Sep2020 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.60B0.00B0.00B1.72B0.60B0.78B0.82B0.71B0.93B1.02B0.90B
Cost of Revenue (Quarter) 0.03B0.03B0.04B0.04B0.06B0.06B0.07B
Gross Profit (Quarter) 0.58B0.75B0.78B0.67B0.87B0.96B0.83B
Operating items
Depreciation & Amortization - Total (Quarter) 0.00B0.00B0.00B
Research & Development (Quarter) -0.34B-0.61B-608.00-721.00-0.34B-0.36B-0.34B-0.36B-0.36B-0.36B-0.44B
Selling, General & Administrative (Quarter) -0.06B-0.08B-81.00-145.00-0.12B-0.13B-0.13B-0.13B-0.14B-0.15B-0.17B
Restructuring Costs (Quarter) -0.03B-0.00B-0.04B
Other Operating Expenses (Quarter) -0.00B-0.00B-0.00B-0.03B-0.03B-0.04B-0.04B-0.06B-0.06B-0.07B
Operating Expenses (Quarter) -0.40B-0.69B-689.00-866.00-0.49B-0.54B-0.51B-0.53B-0.56B-0.56B-0.72B
Operating Income (Quarter) 0.20B0.00351.00858,000.00B0.12B0.24B0.31B0.19B0.36B0.46B0.18B
EBIT (Quarter) 0.20B0.00351.00858,000.00B0.12B0.24B0.31B0.19B0.36B0.46B0.18B
Non-operating items
Interest & Investment Income (Quarter) 448.00356.00616.00-0.30B0.17B-0.28B0.33B-0.65B0.10B-0.25B0.31B0.04B
Other Non Operating Income (Quarter) 0.01B-0.03B0.13B0.01B0.00B0.01B-0.16B
Non Operating Income (Quarter) 0.03B0.35B348.00-187.000.13B-0.06B0.06B0.02B-0.11B
Net income details
EBT (Quarter) 0.23B0.70B699.00671.000.25B0.31B0.25B0.24B0.42B0.48B0.07B
Profit After Tax (Quarter) 0.18B0.54B537.00530.000.19B0.20B0.19B0.20B0.34B0.40B0.05B
Income from Continuing Operations (Quarter) 0.23B0.70B699.00671.000.25B0.31B0.25B0.24B0.42B0.48B0.07B
Consolidated Net Income (Quarter) 0.23B0.70B699.00671.000.25B0.31B0.25B0.24B0.42B0.48B0.07B
Income towards Parent Company (Quarter) 0.23B0.70B699.00671.000.25B0.31B0.25B0.24B0.42B0.48B0.07B
Net Income towards Common Stockholders (Quarter) 0.23B0.70B699.00671.000.25B0.31B0.25B0.24B0.42B0.48B0.07B
Additional items
EPS (Basic) (Quarter) 0.01B59.5720.3210.460.01B0.05B0.03B0.02B0.220.250.04
EPS (Weighted Average and Diluted) (Quarter) 0.01B0.06B20.5410.570.01B0.03B0.02B0.03B0.09B
Shares Outstanding (Weighted Average) (Quarter) 24.030.01B34.4064.160.01B17.746.099.040.01B15.501.90B1.91B0.01B1.92B
Shares Outstanding (Diluted Average) (Quarter) 23.7311.0334.0363.4617.618.9917.5315.3714.900.83
EBITDA (Quarter) 0.18B0.54B542.00506.000.20B0.17B0.32B0.21B0.34B0.41B-0.11B
Interest Expenses (Quarter) -8.00-720.00-0.04B-0.05B-0.10B-0.04B-0.09B-0.04B-0.15B